Výsledky vyhľadávania - "Anti-HIV Agents/therapeutic use"
-
1
Autori: a ďalší
Zdroj: Moseholm, E, Omland, L H, Katzenstein, T L, Pedersen, G, Johansen, I S, Storgaard, M & Weis, N 2025, 'Retention in care and viral suppression in pregnant/postpartum vs. nonpregnant/nonpostpartum women with HIV', AIDS, vol. 39, no. 13, pp. 1936-1945. https://doi.org/10.1097/QAD.0000000000004275
Predmety: Adult, retention in care, Sustained Virologic Response, sustained virologic response, Postpartum Period, Retention in Care/statistics & numerical data, HIV Infections/drug therapy, Pregnancy Complications, Infectious/drug therapy, HIV, Viral Load, Denmark/epidemiology, postpartum period, CD4 Lymphocyte Count, Cohort Studies, Young Adult, Danish HIV birth cohort, Pregnancy, Anti-HIV Agents/therapeutic use, Humans, Female, pregnancy, women, RNA, Viral/blood, Registries
-
2
Autori: a ďalší
Zdroj: The Lancet HIV, 12, 1, pp. e40-e50
Predmety: Adult, Male, Pyridones/administration & dosage, HIV Infections/drug therapy, Diketopiperazines, Middle Aged, Viral/blood, Viral Load/drug effects, Cohort Studies, Treatment Outcome, HIV-1/drug effects, Anti-HIV Agents/therapeutic use, Rilpivirine/therapeutic use, Humans, RNA, Female, Pharmacy, Pharmacology and Toxicology - Radboud University Medical Center, Netherlands
Prístupová URL adresa: https://hdl.handle.net/2066/315836
-
3
Autori: a ďalší
Zdroj: Heje, K B, Lindhardt, M S, Meddis, A, Knudsen, A, Kronborg, G, Weis, N, Lebech, A-M, Kirk, O, Helweg-Larsen, J, Helms, M, Fischer, C P, Hansen, A-B E, Møller, S, Siebner, H R, Hove, J D, Gerstoft, J & Benfield, T 2025, ' No changes in weight, body composition or metabolic parameters after the switch to dolutegravir and lamivudine compared to continued treatment with dolutegravir, abacavir and lamivudine for virologically suppressed HIV infection (The AVERTAS trial) ', BMC Infectious Diseases, vol. 25, 1100 . https://doi.org/10.1186/s12879-025-11334-2
Predmety: Male, Adult, Cyclopropanes, Pyridones, HIV Infections/drug therapy, Dideoxynucleosides/therapeutic use, Middle Aged, Piperazines, Body Composition/drug effects, Drug Combinations, Dideoxyadenosine/analogs & derivatives, Heterocyclic Compounds, 3-Ring/therapeutic use, Anti-HIV Agents/therapeutic use, Oxazines, Humans, Female, Lamivudine/therapeutic use, Body Weight/drug effects
Popis súboru: application/pdf
Prístupová URL adresa: https://curis.ku.dk/ws/files/464179845/s12879-025-11334-2_1_.pdf
-
4
Autori: a ďalší
Zdroj: Sci Rep
Predmety: Adult, Adolescent, Infectious Disease Transmission, Option B+, Loss to follow-up, Kaplan-Meier Estimate, Middle Aged, Ethiopia/epidemiology, Article, Antiretroviral therapy, Cohort Studies, Vertical/prevention & control, Young Adult, HIV Infections/drug therapy epidemiology transmission, Anti-HIV Agents/therapeutic use, Humans, Women, Female, Lost to Follow-Up, Ethiopia, Retrospective Studies, Follow-Up Studies, Proportional Hazards Models
-
5
Autori: a ďalší
Zdroj: AIDS Behav
AIDS and behavior
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Instituto de Investigación Sanitaria La Fe (IIS La Fe)Predmety: Quality of life, Male, Adult, Pyridones, Anti-HIV Agents, HIV Infections, Heterocyclic Compounds, 4 or More Rings, Piperazines, Maintenance Chemotherapy, Humans, Emtricitabine, Cabotegravir, Patient Reported Outcome Measures, Tenofovir, Patient-reported outcome, Original Paper, Long-acting, Adenine, Rilpivirine, Middle Aged, Viral Load, Drug Combinations, Treatment Outcome, Patient Satisfaction, HIV-1, Female, Drug Combinations [MeSH], Tenofovir/analogs, Anti-HIV Agents/therapeutic use [MeSH], Adenine/therapeutic use [MeSH], Pyridones/administration, Patient Satisfaction [MeSH], Pyridones/therapeutic use [MeSH], Emtricitabine/administration, Piperazines [MeSH], Male [MeSH], Rilpivirine/administration, Drug Therapy, Combination [MeSH], Amides [MeSH], Anti-HIV Agents/administration, Adenine/analogs, Female [MeSH], HIV Infections/psychology [MeSH], Diketopiperazines [MeSH], Adult [MeSH], Rilpivirine/therapeutic use [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Tenofovir/administration, Middle Aged [MeSH], Viral Load [MeSH], Patient Reported Outcome Measures [MeSH], Heterocyclic Compounds, 3-Ring/therapeutic use [MeSH], Heterocyclic Compounds, 4 or More Rings/therapeutic use [MeSH], Emtricitabine/therapeutic use [MeSH], HIV Infections/drug therapy [MeSH], Maintenance Chemotherapy [MeSH], Tenofovir/therapeutic use [MeSH]
-
6
Autori: a ďalší
Zdroj: Virdee, A K, Knudtzen, F C, Llibre, J M, Omland, L H, Obel, N, Stærke, N B, Åhsberg, J, Ørsted, I, Kronborg, G, Mohey, R, Montejo, M D P F, Johansen, I S & Martin-Iguacel, R 2024, 'Risk of tuberculosis after achieving HIV virological suppression on antiretroviral therapy: a Danish nationwide prospective cohort study', Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae499
Virdee, A K, Knudtzen, F C, Llibre, J M, Omland, L H, Obel, N, Stærke, N B, Åhsberg, J, Ørsted, I, Kronborg, G, Mohey, R, Montejo, M D P F, Johansen, I S & Martin-Iguacel, R 2025, 'Risk of Tuberculosis After Achieving HIV Virological Suppression on Antiretroviral Therapy : A Danish Nationwide Prospective Cohort Study', Clinical Infectious Diseases, vol. 80, no. 4, pp. 854-863. https://doi.org/10.1093/cid/ciae499Predmety: Male, Adult, Anti-HIV Agents, Denmark, Incidence, HIV Infections/drug therapy, HIV Infections, Middle Aged, Viral Load, antiretroviral therapy (ART), Viral Load/drug effects, Denmark/epidemiology, Risk Factors, Anti-HIV Agents/therapeutic use, Tuberculosis/epidemiology, risk factors, Humans, Tuberculosis, HIV viral suppression, Female, HIV/tuberculosis coinfection, Prospective Studies
-
7
Autori: a ďalší
Prispievatelia: a ďalší
Predmety: HSJ MED, HSAC MED, HCC INF, Adult, Young Adult, Humans, Male, Middle Aged, Anti-HIV Agents / pharmacology, Anti-HIV Agents / therapeutic use, Cluster Analysis, Drug Resistance, Viral* / genetics, HIV Infections* / drug therapy, HIV Infections* / epidemiology, HIV Infections* / transmission, HIV Infections* / virology, HIV-1* / drug effects, HIV-1* / genetics, Homosexuality, Male* / statistics & numerical data, Portugal / epidemiology, Prevalence, Risk Factors
Popis súboru: application/pdf
Dostupnosť: http://hdl.handle.net/10400.17/5132
-
8
Autori: a ďalší
Zdroj: AIDS Behav
AIDS AND BEHAVIOR
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
Fundación de Investigación del Hospital General de Valencia (FIHGUV)Predmety: Male, Adult, Original Paper, Pyridones, Anti-HIV Agents, Lamivudine, Surveys and Questionnaires [MeSH], HIV Treatment Satisfaction Questionnaire, Drug Combinations [MeSH], HIV-1 [MeSH], Patient Satisfaction/statistics, Anti-HIV Agents/therapeutic use [MeSH], Piperazines [MeSH], Dolutegravir, Male [MeSH], Treatment experienced, Anti-HIV Agents/administration, Female [MeSH], HIV Infections/psychology [MeSH], Health-related quality of life, Adult [MeSH], HIV Symptom Distress Module, Humans [MeSH], Treatment Outcome [MeSH], HIV Integrase Inhibitors/therapeutic use [MeSH], Oxazines [MeSH], Lamivudine/administration, Middle Aged [MeSH], Viral Load [MeSH], Patient Reported Outcome Measures [MeSH], Heterocyclic Compounds, 3-Ring/therapeutic use [MeSH], Heterocyclic Compounds, 3-Ring/administration, HIV Integrase Inhibitors/administration, HIV Infections/drug therapy [MeSH], Lamivudine/therapeutic use [MeSH], Pyridones [MeSH], HIV Infections, Middle Aged, Viral Load, Piperazines, Drug Combinations, Treatment Outcome, Patient Satisfaction, Surveys and Questionnaires, Oxazines, HIV-1, Humans, Female, Patient Reported Outcome Measures, HIV Integrase Inhibitors, Heterocyclic Compounds, 3-Ring
-
9
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: ATHENA National Observational Cohort Study 2024, 'Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV : a nationwide, matched, prospective cohort study', The Lancet HIV, vol. 11, no. 9, pp. e576-e585. https://doi.org/10.1016/S2352-3018(24)00150-4
The Lancet HIV, 11, 9, pp. e576-e585Predmety: Male, Adult, Pyridones, Anti-HIV Agents, Drug Substitution, HIV Infections/drug therapy, HIV Infections, Viral Load, Middle Aged, Triazoles, 16. Peace & justice, Viral Load/drug effects, CD4 Lymphocyte Count, 3. Good health, Treatment Outcome, SDG 3 - Good Health and Well-being, Anti-HIV Agents/therapeutic use, Journal Article, Humans, Female, Prospective Studies, Pyridones/therapeutic use, Triazoles/therapeutic use, Pharmacy, Pharmacology and Toxicology - Radboud University Medical Center
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39209387
https://pure.eur.nl/en/publications/18884f4b-3535-4001-aea6-01c28c71d9de
https://doi.org/10.1016/s2352-3018(24)00150-4
https://research.vumc.nl/en/publications/fe2183aa-896f-446d-ba58-0fd5ae96982d
https://dspace.library.uu.nl/handle/1874/455789
https://pure.amsterdamumc.nl/en/publications/2f620819-7426-4a09-9b54-a7636b960b6e
https://doi.org/10.1016/S2352-3018(24)00150-4
https://hdl.handle.net/2066/310801 -
10
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: AIDS
Repisalud
Instituto de Salud Carlos III (ISCIII)
AIDS, vol. 38, no. 10, pp. 1533-1542Predmety: Male, Adult, treatment gap, Treatment gap, Epidemiology and Social, Anti-HIV Agents, antiretroviral therapy, Humans, Female, North America/epidemiology, HIV Infections/mortality, HIV Infections/drug therapy, Europe/epidemiology, Middle Aged, Anti-HIV Agents/therapeutic use, Cohort Studies, Western Europe, HIV Infections, mortality, Antiretroviral therapy, Europe, 03 medical and health sciences, 0302 clinical medicine, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Adherence, North America, adherence, Mortality
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38742863
https://hdl.handle.net/20.500.12105/25435
https://pure.amsterdamumc.nl/en/publications/4640ec93-2953-41a1-8857-067658bcc16a
https://doi.org/10.1097/QAD.0000000000003924
https://serval.unil.ch/notice/serval:BIB_1DF06B603132
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_1DF06B6031324
https://serval.unil.ch/resource/serval:BIB_1DF06B603132.P001/REF.pdf
https://pergamos.lib.uoa.gr/uoa/dl/object/3483258
https://hal.science/hal-04654374v1
https://doi.org/10.1097/qad.0000000000003924
https://hal.science/hal-04654374v1/document -
11
Autori: a ďalší
Zdroj: International Journal of STD & AIDS. 35:710-720
Predmety: Male, Adult, Anti-HIV Agents, Malaysia, Age Factors, HIV Infections, Comorbidity, R Medicine (General), Middle Aged, 3. Good health, Tertiary Care Centers, 03 medical and health sciences, HIV Infections/mortality, 0302 clinical medicine, Risk Factors, Malaysia/epidemiology, Anti-HIV Agents/therapeutic use, Cause of Death, Humans, Female, Aged
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38722271
-
12
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Acta Clinica Belgica. 79:153-159
Predmety: Male, Adult, Anti-HIV Agents, HIV Infections/drug therapy, limited/exhausted treatment options, HIV Infections, Sciences de la santé humaine, Immunologie & maladie infectieuse, extensive treatment history, Belgium, Prevalence, Humans, Viral load, Immunology & infectious disease, Human health sciences, Belgium/epidemiology, Medicine (all), HIV, Middle Aged, Viral Load, multi-drug resistant HIV-1, CD4 Lymphocyte Count, Cross-Sectional Studies, Anti-HIV Agents/therapeutic use, HIV Infections/epidemiology, HIV-1, Female
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38813800
https://biblio.vub.ac.be/vubir/(231c772d-2d15-4319-b2de-b05570bb7fc5).html -
13
Autori: a ďalší
Zdroj: Clinical Infectious Diseases, 79, 5, pp. 1242-1257
Tusch, E, Ryom, L, Pelchen-Matthews, A, Mocroft, A, Elbirt, D, Oprea, C, Günthard, H F, Staehelin, C, Zangerle, R, Suarez, I, Vehreschild, J J, Wit, F, Menozzi, M, d'Arminio Monforte, A, Spagnuolo, V, Pradier, C, Carlander, C, Suanzes, P, Wasmuth, J-C, Carr, A, Petoumenos, K, Borgans, F, Bonnet, F, De Wit, S, El-Sadr, W, Neesgaard, B, Jaschinski, N, Greenberg, L, Hosein, S R, Gallant, J, Vannappagari, V, Young, L, Sabin, C, Lundgren, J, Peters, L, Reekie, J & D:A:D cohort study 2024, 'Trends in Mortality in People With HIV From 1999 through 2020 : a multi-cohort collaboration', Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 79, no. 5, pp. 1242-1257. https://doi.org/10.1093/cid/ciae228Predmety: Medical Microbiology - Radboud University Medical Center, Male, Adult, Anti-HIV Agents, HIV Infections, HIV, cohort collaboration, mortality, observational cohort, people with HIV, 01 natural sciences, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Cause of Death, Humans, Internal Medicine - Radboud University Medical Center, Mortality, 0101 mathematics, HIV, cohort collaboration, mortality, observational cohort, people with HIV, Pharmacy, Pharmacology and Toxicology - Radboud University Medical Center, Middle Aged, 16. Peace & justice, 3. Good health, HIV Infections/mortality, Anti-HIV Agents/therapeutic use, Female
Popis súboru: application/pdf
-
14
Autori: a ďalší
Zdroj: BMC Res Notes
BMC Research Notes, Vol 18, Iss 1, Pp 1-7 (2025)Predmety: Adult, Male, Malawi, Retention in antiretroviral therapy care, Science (General), Ambulatory Care Facilities/economics, QH301-705.5, Anti-HIV Agents, Patient tracing, HIV Infections, Anti-HIV Agents/therapeutic use economics, Ambulatory Care Facilities, Q1-390, Retention in Care, Humans, Cost of routine health interventions, Activity-based costing, Biology (General), HIV Infections/drug therapy economics, Retention in Care/statistics & numerical data economics, Anti-Retroviral Agents/therapeutic use economics, Health Care Costs/statistics & numerical data, Health Care Costs, Prevention of treatment interruption, Research Note, Anti-Retroviral Agents, Medicine, Female
-
15
Autori: a ďalší
Zdroj: AIDS Patient Care and STDs. 38:123-133
Predmety: Anti-HIV agents - therapeutic use, Attitudes of medical personnel, Male, Research methodology, Anti-HIV Agents, Women's health, HIV prevention, Pre-exposure prophylaxis - methods, HIV Infections, Psychology of black people, Socioeconomic factors, Social determinants of health, Black women, Psychology, Humans, Community Health Services, Statistical sampling, HIV infections - drug therapy, Marketing, Community health workers, Health services accessibility, Virginia, Pre-exposure prophylaxis, HIV, Community health services, Community Health and Preventive Medicine, Thematic analysis, United States, Community health care providers, Research funding, Immune System Diseases, Interviewing, Psychosocial factors, Strategic planning, At-risk people, Health promotion, Female, Pre-Exposure Prophylaxis, Sound recordings
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38471092
-
16
Autori: a ďalší
Zdroj: Infection
Predmety: Cohort Studies, Acquired Immunodeficiency Syndrome, 03 medical and health sciences, HIV Infections/complications [MeSH], Acquired Immunodeficiency Syndrome/epidemiology [MeSH], Acquired Immunodeficiency Syndrome/complications [MeSH], Humans [MeSH], Anti-Retroviral Agents/therapeutic use [MeSH], Antiretroviral therapy, Anti-HIV Agents/therapeutic use [MeSH], HIV-related opportunistic infections, Cohort Studies [MeSH], AIDS, CD4 Lymphocyte Count [MeSH], HIV Infections/epidemiology [MeSH], Acquired Immunodeficiency Syndrome/drug therapy [MeSH], HIV Infections/drug therapy [MeSH], Long-term care, Research, Cohort analysis, Clinical surveillance, 0302 clinical medicine, Anti-Retroviral Agents, Anti-HIV Agents, Humans, HIV Infections, CD4 Lymphocyte Count, 3. Good health
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38381307
https://repository.publisso.de/resource/frl:6523542 -
17
Autori: a ďalší
Zdroj: Clin Infect Dis
Clinical infectious diseases, vol. 79, no. 2, pp. 477-486Predmety: Male, Adult, Pyridones, Anti-HIV Agents, Rilpivirine, HIV Infections, Diketopiperazines, Middle Aged, Body Mass Index, 03 medical and health sciences, 0302 clinical medicine, Major Article, Humans, Female, Computer Simulation, Obesity, Rilpivirine/pharmacokinetics, Rilpivirine/administration & dosage, Rilpivirine/therapeutic use, Pyridones/pharmacokinetics, Pyridones/administration & dosage, HIV Infections/drug therapy, Anti-HIV Agents/pharmacokinetics, Anti-HIV Agents/administration & dosage, Anti-HIV Agents/therapeutic use, PBPK modeling, cabotegravir, long-acting, obesity, rilpivirine
Popis súboru: application/pdf
-
18
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: HIV medicine, vol. 24, no. 11, pp. 1126-1136
Predmety: Adult, Acquired Immunodeficiency Syndrome, Adolescent, AIDS-Related Opportunistic Infections, Anti-HIV Agents, COVID-19, ART, EACS, European AIDS Clinical, HIV, Mpox, V12.0, antiretorviral therapy, guidelines, major updates, society, HIV Infections, Child, Humans, Acquired Immunodeficiency Syndrome/drug therapy, AIDS-Related Opportunistic Infections/drug therapy, Anti-HIV Agents/therapeutic use, Anti-Retroviral Agents/therapeutic use, Hepatitis C/drug therapy, HIV Infections/drug therapy, HIV Infections/diagnosis, Lamivudine/therapeutic use, Tenofovir/therapeutic use, Practice Guidelines as Topic, Hepatitis C, 3. Good health, Mpox, Monkeypox, Anti-Retroviral Agents, Lamivudine, Tenofovir
Popis súboru: application/pdf
-
19
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: ISSN: 1058-4838 ; Clinical infectious diseases, vol. 81, no. 1 (2025) p. 57-66.
Predmety: info:eu-repo/classification/ddc/613, info:eu-repo/classification/ddc/616, info:eu-repo/classification/ddc/618, Antiretroviral therapy, Longitudinal study, Low-level viremia, Treatment guidelines, Viral failure, Viremia / blood, Viremia / diagnosis, Viremia / drug therapy, Viremia / virology, HIV-1 / drug effects, HIV-1 / genetics, HIV-1 / isolation & purification, Anti-HIV Agents / pharmacology, Anti-HIV Agents / therapeutic use, Drug Therapy, Combination, Treatment Failure, HIV Infections / blood, HIV Infections / diagnosis, HIV Infections / drug therapy, HIV Infections / virology, Area Under Curve, RNA, Viral / blood, Follow-Up Studies, Prospective Studies, Retrospective Studies
Relation: info:eu-repo/semantics/altIdentifier/pmid/39570670; unige:188927
Dostupnosť: https://archive-ouverte.unige.ch/unige:188927
-
20
Autori: a ďalší
Zdroj: Brown, J A, Motaboli, L, Lerotholi, M, Kohler, M, Haenggi, K, Mokete, M, Chakela, M G, Kao, M, Kopo, M, Mokebe, M, Urda, L, Nsakala, B L, Lukau, B, Ayakaka, I, Amstutz, A, Ehmer, J, Klicpera, A, Klimkait, T, Glass, T, Muhairwe, J, Chammartin, F, Tschumi, N & Labhardt, N D 2025, 'Cohort profile : the Viral load Cohort North-East Lesotho (VICONEL) from 2016 to 2023 - cohort description, test volumes, predictors of viraemia and the road ahead', BMJ Open, vol. 15, no. 2, e085404. https://doi.org/10.1136/bmjopen-2024-085404
Predmety: Humans, Viral Load, Lesotho/epidemiology, Female, Male, HIV Infections/drug therapy, Adult, Middle Aged, Viremia/epidemiology, Prospective Studies, Adolescent, Child, Anti-HIV Agents/therapeutic use, Young Adult
Full Text Finder
Nájsť tento článok vo Web of Science